NO962231L - Prolegemidler av paclitaxelderivater - Google Patents

Prolegemidler av paclitaxelderivater

Info

Publication number
NO962231L
NO962231L NO962231A NO962231A NO962231L NO 962231 L NO962231 L NO 962231L NO 962231 A NO962231 A NO 962231A NO 962231 A NO962231 A NO 962231A NO 962231 L NO962231 L NO 962231L
Authority
NO
Norway
Prior art keywords
drugs
paclitaxel derivatives
paclitaxel
derivatives
Prior art date
Application number
NO962231A
Other languages
English (en)
Other versions
NO315233B1 (no
NO962231D0 (no
Inventor
Paul M Scola
Dolatrai M Vyas
John F Kadow
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO962231D0 publication Critical patent/NO962231D0/no
Publication of NO962231L publication Critical patent/NO962231L/no
Publication of NO315233B1 publication Critical patent/NO315233B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6551—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
    • C07F9/65512—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems
NO19962231A 1995-06-06 1996-05-31 Prolegemidler av paclitaxelderivater NO315233B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46924795A 1995-06-06 1995-06-06

Publications (3)

Publication Number Publication Date
NO962231D0 NO962231D0 (no) 1996-05-31
NO962231L true NO962231L (no) 1996-12-09
NO315233B1 NO315233B1 (no) 2003-08-04

Family

ID=23863053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19962231A NO315233B1 (no) 1995-06-06 1996-05-31 Prolegemidler av paclitaxelderivater

Country Status (23)

Country Link
EP (1) EP0747385B1 (no)
JP (1) JPH08337589A (no)
KR (1) KR100375956B1 (no)
CN (1) CN1066151C (no)
AR (1) AR002756A1 (no)
AT (1) ATE222259T1 (no)
AU (1) AU695959B2 (no)
CA (1) CA2176191A1 (no)
CZ (1) CZ291516B6 (no)
DE (1) DE69622933T2 (no)
DK (1) DK0747385T3 (no)
ES (1) ES2181824T3 (no)
HU (1) HUP9601524A3 (no)
IL (1) IL118526A (no)
MX (1) MX9601994A (no)
NO (1) NO315233B1 (no)
NZ (1) NZ286723A (no)
PL (1) PL187883B1 (no)
PT (1) PT747385E (no)
RU (1) RU2162082C2 (no)
SG (1) SG72692A1 (no)
TW (1) TW354293B (no)
ZA (1) ZA964261B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
BR9809694A (pt) * 1997-05-27 2000-10-03 Baker Norton Pharma Processo e composição para administração de taxanos oralmente a pacientes humanos
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
CA2358925C (en) * 1999-02-18 2010-04-20 Oxigene, Inc. Compositions and methods for use in targeting vascular destruction
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
AR030188A1 (es) 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
NZ514380A (en) 2000-02-02 2005-03-24 Univ Florida State Res Found C7 carbonate substituted taxanes as antitumor agents
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6916942B2 (en) 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
US7063977B2 (en) 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
KR20030049023A (ko) * 2001-12-13 2003-06-25 주식회사 코오롱 방사선 감작제용 파클리탁셀 유도체
GT200500041A (es) 2004-03-05 2005-10-24 Taxanos con sustituyente lactiloxilo en el c7
EP2896412A1 (en) * 2005-02-18 2015-07-22 Abraxis BioScience, LLC Drugs with improved hydrophobicity for incorporation in medical devices
US20160024084A1 (en) 2013-03-15 2016-01-28 Concert Pharmaceuticals, Inc. Deuterated palbociclib
WO2015009889A1 (en) 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
WO2017087594A1 (en) * 2015-11-19 2017-05-26 Biohaven Pharmaceutical Holding Company Ltd. Amine prodrugs of pharmaceutical compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO310238B1 (no) * 1992-12-24 2001-06-11 Bristol Myers Squibb Co Kjemiske forbindelser og farmasöytisk preparat samt anvendelse av slike preparater
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives

Also Published As

Publication number Publication date
SG72692A1 (en) 2000-05-23
TW354293B (en) 1999-03-11
PL314637A1 (en) 1996-12-09
JPH08337589A (ja) 1996-12-24
CZ156396A3 (en) 1996-12-11
DK0747385T3 (da) 2002-12-16
MX9601994A (es) 1997-08-30
EP0747385B1 (en) 2002-08-14
PL187883B1 (pl) 2004-10-29
CN1066151C (zh) 2001-05-23
AU695959B2 (en) 1998-08-27
CZ291516B6 (cs) 2003-03-12
ATE222259T1 (de) 2002-08-15
HUP9601524A3 (en) 2000-03-28
IL118526A (en) 2001-05-20
EP0747385A1 (en) 1996-12-11
KR970000222A (ko) 1997-01-21
PT747385E (pt) 2002-11-29
ZA964261B (en) 1997-11-27
HU9601524D0 (en) 1996-07-29
KR100375956B1 (ko) 2003-04-21
ES2181824T3 (es) 2003-03-01
NO315233B1 (no) 2003-08-04
DE69622933D1 (de) 2002-09-19
RU2162082C2 (ru) 2001-01-20
CA2176191A1 (en) 1996-12-07
DE69622933T2 (de) 2003-04-24
AR002756A1 (es) 1998-04-29
AU5471896A (en) 1996-12-19
IL118526A0 (en) 1996-10-16
NO962231D0 (no) 1996-05-31
NZ286723A (en) 1998-03-25
CN1144805A (zh) 1997-03-12
HUP9601524A2 (en) 1997-05-28

Similar Documents

Publication Publication Date Title
NO974466D0 (no) Anvendelse av fumagillol og derivater derav for fremstilling av medikamenter mot tarminfeksjoner
NO962231D0 (no) Prolegemidler av paclitaxelderivater
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
EE9800227A (et) 17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid
NO995113D0 (no) Substituerte benzopyranderivater for behandling av inflammasjon
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
NO20002443L (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
DE69628353D1 (de) Benzopyran enthaltende Verbindungen und deren Prodrugformen
NO982809L (no) Prolegemidler av tombin-inhibitorer
NO953244D0 (no) Derivater av cyklodepeptid PF 1022
PT858325E (pt) Formulacao farmaceutica liofilizada estavel
NO973938D0 (no) Farmasöytisk preparat av piperdinoalkanolforbindelser
DE69603269D1 (de) Derivate von inulin
NO20005187D0 (no) n-sats syntese av 2-oksazolidinonderivater
BR9610214A (pt) Compostos farmacéuticos
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
FI973124A0 (fi) D-vitamiinijohdannaisten dermatologinen käyttö
ATE224891T1 (de) Chromon-derivate
FI944016A0 (fi) Makrolidien fluorisokerijohdannaiset
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
NO981537L (no) FremgangsmÕte for fremstilling av antimalariamedikamenter
BR9609723A (pt) Derivados da tricetona
NO965448D0 (no) Farmasöytiske forbindelser
NO974143D0 (no) Farmakologisk anvendelse av visse cystinderivater
NO974458D0 (no) Fremstilling av cis-4-O-beskyttede-2-cyklopentenolderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application